healthandpharma1d
How AI is Shaping Drug Discovery: LP-300's Breakthrough in Lung Cancer Treatment
AI-Enabled Drug Discovery is on the verge of a new revolution, with the first data emerging from exciting research indicating ...
healthandpharma2d
How Novel Immunotherapy IMNN-001 Could Change Ovarian Cancer Outcomes
The groundbreaking results of the OVATION 2 Study demonstrated a substantial 35% improvement in overall survival, equating to ...
healthandpharma6d
FDA Approves Ziihera as First Dual HER2-Targeted Therapy for Biliary Tract Cancer
The US Food and Drug Administration (FDA) has granted accelerated approval to Ziihera (zanidatamab-hrii), a novel therapy for ...
healthandpharma6d
How the ARANOTE Trial Results Could Advance Prostate Cancer Treatment
ONCOLife proudly presents an exclusive interview with Dr. Iris Kuss, VP and Global Development Lead Oncology at Bayer. In ...
healthandpharma5d
FDA Greenlights Revumenib for Relapsed Leukemia Treatment, First Administered at FCS
The U.S. Food and Drug Administration (FDA) has approved revumenib, a pioneering drug for relapsed or refractory acute ...
healthandpharma8d
How Oncolytic Viruses Could Be a New Frontier in Transforming Cancer Treatment
Oncolytic viruses are a very promising class of therapeutic agents, with a broad range of types. In this exclusive interview ...
healthandpharma9d
Cambridge Researchers Launch Groundbreaking Study to Uncover Cancer Survival Secrets
Researchers from Cambridge University Hospitals, in collaboration with the NHS Health Research Authority, have launched the ...